Veeva Systems Inc Cl-a — Business Overview
What does Veeva do?
Veeva is a cloud software and data company built exclusively for the life sciences industry. It sells software, data products, and consulting services to pharmaceutical, biotechnology, and medical device companies — helping them run clinical trials, manage drug safety and regulatory submissions, market and sell their products, and maintain quality and compliance. As of January 31, 2026, Veeva served 1,552 customers, ranging from giants like Novartis and Eli Lilly to smaller biotech startups. The company had 7,928 employees worldwide.
Veeva organizes its offerings into four product clouds, plus professional and consulting services:
| Product Category | What it does | Reporting Segment |
|---|---|---|
| Veeva Development Cloud | Software for clinical trials, regulatory submissions, and drug safety | R&D and Quality Solutions |
| Veeva Quality Cloud | Quality management and compliance software for manufacturing and lab operations | R&D and Quality Solutions |
| Veeva Commercial Cloud | CRM (customer relationship management), marketing, and medical affairs tools for sales teams | Commercial Solutions |
| Veeva Data Cloud | Reference data, analytics, and patient data products for commercial and clinical use | Commercial Solutions |
| Professional Services | Implementation, configuration, training, and managed services | — |
| Business Consulting | Strategic consulting for commercial and R&D operations | — |
How does Veeva make money?
Veeva earns most of its revenue from subscriptions to its cloud software and data products. Customers pay recurring fees to access its applications (like its CRM suite or clinical trial management tools) and to subscribe to data products (like Veeva OpenData, which provides reference data on healthcare professionals). This subscription model creates predictable, recurring revenue.
Professional services and business consulting provide a second, services-based revenue stream. Veeva charges customers for implementation help, configuration, training, and ongoing system management. It also offers higher-level strategic consulting through its Veeva Business Consulting arm, which advises clients on commercial strategy, field force optimization, and drug development processes. These services are separate from its software subscriptions and tend to support deeper customer relationships.
What market does Veeva operate in?
Veeva operates at the intersection of enterprise cloud software and the global life sciences industry. Its customers are pharmaceutical, biotech, and medical device companies — an industry defined by heavy regulation, long product development cycles (drug development can take over a decade), and high compliance requirements. Those characteristics make specialized, validated software essential rather than optional.
Secular tailwinds are working in Veeva's favor. The life sciences industry is undergoing a long migration away from older, on-premise legacy software (from vendors like Oracle and Microsoft) toward cloud-based, integrated platforms. Clinical trials are also growing in complexity, regulatory requirements keep expanding globally, and the industry's push to accelerate time-to-market for drugs creates ongoing demand for the efficiency gains Veeva's tools promise. Additionally, the filing notes that Veeva is adding agentic AI (AI that can autonomously take actions within workflows) to its platform via Veeva AI Agents, positioning it for the next wave of software adoption.
Who are Veeva's main competitors?
Veeva's most formidable competitor across several product lines is IQVIA Holdings. IQVIA competes directly with Veeva's data products (Veeva Data Cloud and Crossix), and also offers applications that overlap with Veeva's Development Cloud and Quality Cloud. Notably, IQVIA licensed its CRM software to Salesforce, which is now Veeva's primary competitor in the CRM space. Salesforce has built a life sciences-specific CRM product that goes head-to-head with Veeva's flagship Vault CRM and legacy Veeva CRM.
Other competitors are more narrowly focused on specific product areas:
- CRM: Salesforce (primary competitor)
- Data products: IQVIA, Ipsos, Definitive Health, and smaller data providers
- Development and Quality Cloud: Dassault Systèmes, OpenText, Oracle, Honeywell, and smaller niche vendors
- Consulting and services: A broad range of professional services firms
Veeva's core competitive advantage is deep industry specialization. Because it focuses entirely on life sciences, it can build regulatory compliance directly into its products, adapt quickly to changing rules (like FDA or EU requirements), and develop functionality that a general-purpose vendor like Salesforce or Microsoft would be slow to prioritize. Veeva also points to its large installed customer base, high customer satisfaction, and the breadth of its integrated platform — covering everything from clinical trials to commercial sales — as key advantages. The filing acknowledges that some competitors have larger financial resources and stronger brand recognition in adjacent markets, so competition is expected to intensify.
Where does Veeva operate?
Veeva is a global business with operations spanning multiple continents, though the filing does not break out revenue by region. Its data centers are located in the United States, the European Union, Japan, South Korea, Singapore, Australia, and Brazil. Products used within China are hosted on separate data centers located in China, which reflects the distinct regulatory and data-sovereignty requirements of that market.
Veeva sells directly to life sciences companies worldwide through its own sales organization. Its largest customers — including Bayer, Boehringer Ingelheim, Novartis, and Merck — are multinational companies with global operations, meaning Veeva's software supports users across many countries even when the commercial relationship is managed centrally. The company has privacy and compliance programs aligned to GDPR (EU), UK GDPR, CCPA (California), and HIPAA (U.S.), reflecting genuine cross-border data handling responsibilities.